CBT
Rank #296Rank #296 by gross profitability (GP/assets 0.24) · ROE 21.1% · Piotroski F-Score 6 / 9.
As-of 2026-07-22 · CIK 0000016040 · all metrics point-in-time as of the filing date.
Financials
Each fiscal year is read as-of that year’s own 10-K filing, so nothing restated after the fact leaks backwards. Line items this filer never tagged are omitted. Hover or tap a badge for the diagnostic behind it.
| Fiscal year end | 2025-09-30filed 2025-11-24 | 2024-09-30filed 2024-11-20 | 2023-09-30filed 2023-11-22 | 2022-09-30filed 2022-11-23 |
|---|---|---|---|---|
| Revenue | 3,713.0 | 3,994.0 | 3,931.0 | 4,321.0 |
| Revenue growth (YoY) | -7.0% | 1.6% | -9.0% | 26.8% |
| Cost of revenue | 2,773.0 | 3,034.0 | 3,092.0 | 3,436.0 |
| Gross profit | 940.0 | 960.0 | 839.0 | 885.0 |
| Gross margin | 25.3% | 24.0% | 21.3% | 20.5% |
| Selling, general & administrative | 260.0 | 283.0 | 253.0 | 258.0 |
| Research & development | 59.0 | 63.0 | 57.0 | 55.0 |
| Operating income | 621.0 | 614.0 | 526.0 | 389.0 |
| Operating margin | 16.7% | 15.4% | 13.4% | 9.0% |
| Interest expense | 76.0 | 81.0 | 90.0 | 56.0 |
| Pre-tax income | 565.0 | 529.0 | 451.0 | 335.0 |
| Income tax expense | 196.0 | 111.0 | (28.0) | 102.0 |
| Net income | 331.0 | 380.0 | 445.0 | 209.0 |
| Net margin | 8.9% | 9.5% | 11.3% | 4.8% |
| EPS (basic) | $6.07 | $6.79 | $7.79 | $3.65 |
| EPS (diluted) | $6.02 | $6.72 | $7.73 | $3.62 |
Figures are as originally filed with the SEC (point-in-time), not restated, so they can differ slightly from sites that show later-restated numbers. Why point-in-time?